Andrew Offer

Andrew Offer has been a member of the MiNDERA Board of Directors since 2015. He is a General Partner and the Chief Executive Officer of Scientific Health Development. With over 15 years of healthcare investment experience, Mr. Offer serves on the board of directors for most active SHD portfolio companies including Sight Sciences (Nasdaq: SGHT), in addition to historically acting in the capacity of Chief Financial Officer for multiple portfolio companies. Prior to joining SHD, he spent more than 3 years at VMG Health, where he excelled in business valuation exclusively in the healthcare industry. Mr. Offer graduated Magna Cum Laude with multiple honors distinctions earning a B.B.A. in Finance from Texas A&M University. In addition, Mr. Offer earned the Chartered Financial Analyst (CFA) designation in 2009 and is a member of the CFA Institute and the CFA Society of Dallas-Fort Worth.

Featured Articles

Mindera’s SkinAtlas is a scalable platform that leverages artificial intelligence and machine learning to analyze patient-specific data collected from a dermal biomarker patch.


Mindera Newsletter

Stay ahead in the world of psoriasis treatment!

Subscribe to our newsletter and stay updated on the latest breakthroughs in biologic treatments.